These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26026393)

  • 1. Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.
    Mehta RS; Chong DQ; Song M; Meyerhardt JA; Ng K; Nishihara R; Qian Z; Morikawa T; Wu K; Giovannucci EL; Fuchs CS; Ogino S; Chan AT
    Gastroenterology; 2015 Sep; 149(3):614-22. PubMed ID: 26026393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer.
    Mehta RS; Song M; Bezawada N; Wu K; Garcia-Albeniz X; Morikawa T; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
    J Natl Cancer Inst; 2014 Apr; 106(4):dju016. PubMed ID: 24565956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.
    Mima K; Nishihara R; Yang J; Dou R; Masugi Y; Shi Y; da Silva A; Cao Y; Song M; Nowak J; Gu M; Li W; Morikawa T; Zhang X; Wu K; Baba H; Giovannucci EL; Meyerhardt JA; Chan AT; Fuchs CS; Qian ZR; Ogino S
    Clin Cancer Res; 2016 Aug; 22(15):3841-8. PubMed ID: 26957558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.
    Kosumi K; Hamada T; Zhang S; Liu L; da Silva A; Koh H; Twombly TS; Mima K; Morikawa T; Song M; Nowak JA; Nishihara R; Saltz LB; Niedzwiecki D; Ou FS; Zemla T; Mayer RJ; Baba H; Ng K; Giannakis M; Zhang X; Wu K; Giovannucci EL; Chan AT; Fuchs CS; Meyerhardt JA; Ogino S
    Eur J Cancer; 2019 Apr; 111():82-93. PubMed ID: 30826660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Coffee Intake After Diagnosis of Colorectal Cancer and Reduced Mortality.
    Hu Y; Ding M; Yuan C; Wu K; Smith-Warner SA; Hu FB; Chan AT; Meyerhardt JA; Ogino S; Fuchs CS; Giovannucci EL; Song M
    Gastroenterology; 2018 Mar; 154(4):916-926.e9. PubMed ID: 29158191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediagnostic Plasma Adiponectin and Survival among Patients with Colorectal Cancer.
    Chong DQ; Mehta RS; Song M; Kedrin D; Meyerhardt JA; Ng K; Wu K; Fuchs CS; Giovannucci EL; Ogino S; Chan AT
    Cancer Prev Res (Phila); 2015 Dec; 8(12):1138-45. PubMed ID: 26382604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.
    Yamauchi M; Lochhead P; Imamura Y; Kuchiba A; Liao X; Qian ZR; Nishihara R; Morikawa T; Shima K; Wu K; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT; Ogino S
    Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1142-52. PubMed ID: 23629521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer.
    Ng K; Meyerhardt JA; Wu K; Feskanich D; Hollis BW; Giovannucci EL; Fuchs CS
    J Clin Oncol; 2008 Jun; 26(18):2984-91. PubMed ID: 18565885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Chemerin Plasma Concentration With Risk of Colorectal Cancer.
    Eichelmann F; Schulze MB; Wittenbecher C; Menzel J; Weikert C; di Giuseppe R; Biemann R; Isermann B; Fritsche A; Boeing H; Aleksandrova K
    JAMA Netw Open; 2019 Mar; 2(3):e190896. PubMed ID: 30901045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer.
    Olsen RS; Nijm J; Andersson RE; Dimberg J; Wågsäter D
    World J Gastroenterol; 2017 Sep; 23(34):6212-6219. PubMed ID: 28974887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes.
    Mehta RS; Song M; Nishihara R; Drew DA; Wu K; Qian ZR; Fung TT; Hamada T; Masugi Y; da Silva A; Shi Y; Li W; Gu M; Willett WC; Fuchs CS; Giovannucci EL; Ogino S; Chan AT
    Gastroenterology; 2017 Jun; 152(8):1944-1953.e1. PubMed ID: 28249812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin use and survival after diagnosis of colorectal cancer.
    Chan AT; Ogino S; Fuchs CS
    JAMA; 2009 Aug; 302(6):649-58. PubMed ID: 19671906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma.
    Sun L; Guo C; Burnett J; Yang Z; Ran Y; Sun D
    Oncotarget; 2016 Nov; 7(48):78688-78697. PubMed ID: 27780921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
    Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
    Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women.
    Song M; Mehta RS; Wu K; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
    Cancer Prev Res (Phila); 2016 Jan; 9(1):27-34. PubMed ID: 26511487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer.
    Sun B; Li Y; Zhou Y; Ng TK; Zhao C; Gan Q; Gu X; Xiang J
    J Cell Physiol; 2019 Feb; 234(2):1416-1425. PubMed ID: 30078189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood markers of oxidative stress are strongly associated with poorer prognosis in colorectal cancer patients.
    Boakye D; Jansen L; Schöttker B; Jansen EHJM; Schneider M; Halama N; Gào X; Chang-Claude J; Hoffmeister M; Brenner H
    Int J Cancer; 2020 Nov; 147(9):2373-2386. PubMed ID: 32319674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.
    Liao X; Lochhead P; Nishihara R; Morikawa T; Kuchiba A; Yamauchi M; Imamura Y; Qian ZR; Baba Y; Shima K; Sun R; Nosho K; Meyerhardt JA; Giovannucci E; Fuchs CS; Chan AT; Ogino S
    N Engl J Med; 2012 Oct; 367(17):1596-606. PubMed ID: 23094721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy.
    Wang XB; Jiang XR; Yu XY; Wang L; He S; Feng FY; Guo LP; Jiang W; Lu SH
    Cancer Sci; 2014 Feb; 105(2):176-85. PubMed ID: 24383865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating inflammatory markers and colorectal cancer risk: A prospective case-cohort study in Japan.
    Song M; Sasazuki S; Camargo MC; Shimazu T; Charvat H; Yamaji T; Sawada N; Kemp TJ; Pfeiffer RM; Hildesheim A; Pinto LA; Rabkin CS; Tsugane S
    Int J Cancer; 2018 Dec; 143(11):2767-2776. PubMed ID: 30132835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.